Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Rosuvastatin
The First People's Hospital of Lianyungang
Hyperlipidemia
1 trial -
Rosuvastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Infarction, Anterior Cerebral Artery
1 trial -
Rosuvastatin (5mgοΌ10mgοΌ20mg)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carotid Atherosclerosis
1 trial -
Rosuvastatin and Ezetimibe morning or evening administration
COLLEGIUM PHARMACEUTICAL, INC
Hypercholesterolemia
1 trial -
Simvastatin
Hospital Authority, Hong Kong
Obesity
1 trial -
Statin
The First People's Hospital of Lianyungang
Acute Coronary Syndrome
1 trial -
WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL
Fondazione Telethon ETS
Myocardial infarction with non-obstructive coronary arteries (MINOCA)
1 trial -
ulinastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatitis
1 trial -
Atorvastatin
Shi Yang
Sleep Deprivation
1 trial -
Atorvastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atherosclerosis
1 trial -
Atorvastatin
The First People's Hospital of Lianyungang
Contrast-induced Acute Kidney Injury
1 trial -
Atorvastatin 20 Mg Oral Tablet
The First People's Hospital of Lianyungang
Atherosclerotic Cardiovascular Disease
1 trial -
Atorvastatin Calcium 20Mg Tab
The First People's Hospital of Lianyungang
Hyperlipidemias
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Statin
1 trial -
Pitavastatin and placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial -
Placebo plus high-intensity statin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Simvastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hyperlipidemias
1 trial -
Statin
Hospital Authority, Hong Kong
HCC
1 trial -
Ulinastatin
The First People's Hospital of Lianyungang
Acute Respiratory Distress Syndrome
1 trial -
Ulinastatin and Thymosin Ξ±1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aortic Dissection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources